DOI QR코드

DOI QR Code

Traditional Herbal Medicine Yukmijihwang-won Alleviates Reserpine-Induced Pain and Depression-Like Behavior in Mice

  • Kang, Dong-Wook (Department of Physiology and Medical Science, College of Medicine and Brain Research Institute, Chungnam National University) ;
  • Lee, Jiyoon (Department of Neuropsychiatry, Dunsan Korean Medicine Hospital of Daejeon University) ;
  • Choi, Jae-Gyun (Department of Physiology and Medical Science, College of Medicine and Brain Research Institute, Chungnam National University) ;
  • Kim, Jaehyuk (Department of Physiology and Medical Science, College of Medicine and Brain Research Institute, Chungnam National University) ;
  • Kim, Ju-Yeon (Department of Neuropsychiatry, Dunsan Korean Medicine Hospital of Daejeon University) ;
  • Park, Jin Bong (Department of Physiology and Medical Science, College of Medicine and Brain Research Institute, Chungnam National University) ;
  • Jung, In Chul (Department of Neuropsychiatry, Dunsan Korean Medicine Hospital of Daejeon University) ;
  • Kim, Hyun-Woo (Department of Physiology and Medical Science, College of Medicine and Brain Research Institute, Chungnam National University)
  • Received : 2020.12.01
  • Accepted : 2020.12.18
  • Published : 2020.12.30

Abstract

Objectives: Yukmijihwang-won (Liuweidihuang-wan in Chinese) is a frequently used medicinal herbal formula. It is used as Yin tonic in Korea and China to recover patients from Yin deficiency. However, the scientific evidence on this drug has not revealed the beneficial effect or mechanism of its effects on the neurological disorder. We designed this study to examine the antidepressive and analgesic effects of Yukmijihwang-won (YJ-01) and the minor modification of YJ-01, YJ-06 on the reserpine-induced pain-depression dyad mice model. Methods: Reserpine (1 mg/kg) was administered subcutaneously once a day for three consecutive days to induce pain and depression-like behavior. The oral administration of YJ-01 and YJ-06 (100, 200, or 300 mg/kg) was performed once daily from three days after the reserpine injection. Results: Repeated administration of the YJs significantly reduced the immobility time in a forced swimming test and increased the moved distance and number of crossings in the open field test. In the von-Frey filament test, the oral administration of YJs remarkably suppressed the increase in paw withdrawal frequency. Conclusions: The results of this study suggest that YJ-01 and 06 may be good candidates to treat the pain-depression dyad.

Keywords

References

  1. Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci. 2006;7(2):137-51. https://doi.org/10.1038/nrn1846
  2. Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: a World Health Organization Study in Primary Care. JAMA. 1998;280(2):147-51. https://doi.org/10.1001/jama.280.2.147
  3. Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163(20):2433-45. https://doi.org/10.1001/archinte.163.20.2433
  4. Miller LR, Cano A. Comorbid chronic pain and depression: who is at risk? J Pain. 2009;10(6):619-27. https://doi.org/10.1016/j.jpain.2008.12.007
  5. Ohayon MM, Schatzberg AF. Using chronic pain to predict depressive morbidity in the general population. Arch Gen Psychiatry. 2003;60(1):39-47. https://doi.org/10.1001/archpsyc.60.1.39
  6. Leith NJ, Barrett RJ. Effects of chronic amphetamine or reserpine on self-stimulation responding: animal model of depression? Psychopharmacology (Berl). 1980;72(1): 9-15. https://doi.org/10.1007/BF00433801
  7. Nagakura Y, Oe T, Aoki T, Matsuoka N. Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia. Pain. 2009;146(1-2):26-33. https://doi.org/10.1016/j.pain.2009.05.024
  8. Arora V, Kuhad A, Tiwari V, Chopra K. Curcumin ameliorates reserpine-induced pain-depression dyad: behavioural, biochemical, neurochemical and molecular evidences. Psychoneuroendocrinology. 2011;36(10):1570-81. https://doi.org/10.1016/j.psyneuen.2011.04.012
  9. Zhang A, Sun H, Qiu S, Wang X. Advancing drug discovery and development from active constituents of yinchenhao tang, a famous traditional chinese medicine formula. Evid Based Complement Alternat Med. 2013;2013:257909.
  10. Ha H, Lee JK, Lee HY, Koh WS, Seo CS, Lee MY, et al. Safety Evaluation of Yukmijihwang-tang: Assessment of Acute and Subchronic Toxicity in Rats. Evid Based Complement Alternat Med. 2011;2011:672136.
  11. Liang X, Li H, Li S. A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study. Mol Biosyst. 2014;10(5):1014-22. https://doi.org/10.1039/c3mb70507b
  12. Kitagawa I, Fukuda Y, Taniyama T, Yoshikawa M. [Chemical studies on crude drug processing. X. On the constituents of rehmanniae radix (4): comparison of the constituents of various rehmanniae radixes originating in China, Korea, and Japan]. Yakugaku Zasshi. 1995;115(12): 992-1003. https://doi.org/10.1248/yakushi1947.115.12_992
  13. Kubo M, Asano T, Matsuda H, Yutani S, Honda S. [Studies on Rehmanniae radix. III. The relation between changes of constituents and improvable effects on hemorheology with the processing of roots of Rehmannia glutinosa]. Yakugaku Zasshi. 1996;116(2):158-68. https://doi.org/10.1248/yakushi1947.116.2_158
  14. Zhang ND, Han T, Huang BK, Rahman K, Jiang YP, Xu HT, et al. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery. J Ethnopharmacol. 2016;189:61-80. https://doi.org/10.1016/j.jep.2016.05.025
  15. Zhou W, Cheng X, Zhang Y. Effect of Liuwei Dihuang decoction, a traditional Chinese medicinal prescription, on the neuroendocrine immunomodulation network. Pharmacol Ther. 2016;162:170-8. https://doi.org/10.1016/j.pharmthera.2016.02.004
  16. Zhao BB, Long QH, Wang CY, Chen LL, Xie GJ, Bo WJ, et al. Protective Effects of Liu Wei Di Huang Wan on the Liver, Orbitofrontal Cortex Nissl Bodies, and Neurites in MSG+ PH-Induced Liver Regeneration Rat Model. Evid Based Complement Alternat Med. 2018;2018:9090128.
  17. Blasco-Serra A, Escrihuela-Vidal F, Gonzalez-Soler EM, Martinez-Exposito F, Blasco-Ausina MC, Martinez-Bellver S, et al. Depressive-like symptoms in a reserpine-induced model of fibromyalgia in rats. Physiol Behav. 2015;151:456-62. https://doi.org/10.1016/j.physbeh.2015.07.033
  18. Wu YY, Jiang YL, He XF, Zhao XY, Shao XM, Du JY, et al. Effects of Electroacupuncture with Dominant Frequency at SP 6 and ST 36 Based on Meridian Theory on Pain-Depression Dyad in Rats. Evid Based Complement Alternat Med. 2015;2015:732845.
  19. Region WWP. WHO International Standard Terminologies on Traditional Medicine in the Western Pacific Region. Data. WLCiP, editor: World Health Organization; 2007.
  20. Cheng TO. Danshen: a popular chinese cardiac herbal drug. J Am Coll Cardiol. 2006;47(7):1498; author reply 9-500. https://doi.org/10.1016/j.jacc.2006.01.001
  21. Maione F, Mascolo N. Danshen and the Cardiovascular System: New Advances for an Old Remedy. Semin Thromb Hemost. 2016;42(3):321-2. https://doi.org/10.1055/s-0036-1580086
  22. Su CY, Ming QL, Rahman K, Han T, Qin LP. Salvia miltiorrhiza: Traditional medicinal uses, chemistry, and pharmacology. Chin J Nat Med. 2015;13(3):163-82. https://doi.org/10.1016/S1875-5364(15)30002-9
  23. Wang T, Fu X, Wang Z. Danshen Formulae for Cancer: A Systematic Review and Meta-Analysis of High-Quality Randomized Controlled Trials. Evid Based Complement Alternat Med. 2019;2019:2310639.
  24. Commission CP. Pharmacopoeia of the People's Republic of China. Beijing: China MedicalScience Press; 2015.
  25. Lin HC, Ding HY, Ko FN, Teng CM, Wu YC. Aggregation inhibitory activity of minor acetophenones from Paeonia species. Planta Med. 1999;65(7):595-9. https://doi.org/10.1055/s-1999-14030
  26. Tatsumi S, Mabuchi T, Abe T, Xu L, Minami T, Ito S. Analgesic effect of extracts of Chinese medicinal herbs Moutan cortex and Coicis semen on neuropathic pain in mice. Neurosci Lett. 2004;370(2-3):130-4. https://doi.org/10.1016/j.neulet.2004.08.043
  27. H. Wagner HH, N.R. Farnsworth (Eds.). Recent research on oriental medicinal plants. Economic and Medicinal Plant Research. 1985:53-85.
  28. Hattori T, Hayashi K, Nagao T, Furuta K, Ito M, Suzuki Y. Studies on antinephritic effects of plant components (3): Effect of pachyman, a main component of Poria cocos Wolf on original-type anti-GBM nephritis in rats and its mechanisms. Jpn J Pharmacol. 1992;59(1):89-96. https://doi.org/10.1254/jjp.59.89
  29. Tai T, Akita Y, Kinoshita K, Koyama K, Takahashi K, Watanabe K. Anti-emetic principles of Poria cocos. Planta Med. 1995; 61(6):527-30. https://doi.org/10.1055/s-2006-959363
  30. Tseng J, Chang JG. Suppression of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6 and granulocyte-monocyte colony stimulating factor secretion from human monocytes by an extract of Poria cocos. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1992; 25(1):1-11.